Stocks
Quoin Pharmaceuticals, Ltd.QNRX
NASDAQHealthcareBiotechnology$4.02
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing novel therapies for rare and orphan diseases, with a focus on dermatological and oncological conditions. Its pipeline includes treatments for Netherton syndrome and other skin disorders, positioning it as a speculative play on regulatory milestones and clinical trial outcomes.
52W Range: $3.25-$23.50
Congressional Interest in Quoin Pharmaceuticals, Ltd. (QNRX)
No congressional trades have been disclosed for Quoin Pharmaceuticals, Ltd. (QNRX) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading QNRX?
No congressional trades found for this stock.